UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A stock index aggregates price data to reflect overall market movement. Explore its construction and what factors influence its value.
28,657 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
Regulators deliver a landmark clarification for crypto assets, signaling non-securities for most tokens. But the fram...
As the 2026 COLA lands at 2.8%, retirees face a growing gap between checks and living costs. A disciplined four-ETF i...
Gold flirts with bear-market as risk appetite wobbles amid rising rates and Middle East tensions. Traders weigh margi...
A new generation rewrites the wealth playbook, stacking income streams and investing smarter as traditional paths gro...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
The Nasdaq Composite rises as cooling inflation and strong chip profits lift tech shares, setting the tone for a summ...
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
The U.S. Treasury has designated SPYM as the default ETF for newborn accounts, depositing a $1,000 contribution into ...
U.S. stocks wobbled Friday as the Russell 2000 slipped, but the small-cap rally remains a defining thread of 2026. In...